autism spectrum disorder

autism spectrum disorder
Field	Psychiatry, Pediatrics, Clinical psychology
Onset	Early childhood
Duration	Lifelong
Causes	Genetic and environmental factors
Diagnosis	Based on behavior and development
Treatment	Behavioral therapy, Speech therapy, Educational support
Prognosis	Varies widely
Frequency	~1% of people worldwide

autism spectrum disorder. Autism spectrum disorder (ASD) is a neurodevelopmental condition characterized by persistent challenges in social communication and interaction, alongside restricted, repetitive patterns of behavior, interests, or activities. Symptoms are typically recognized in early childhood and vary widely in presentation and severity across individuals. The condition is diagnosed based on behavioral observation and developmental history, with no single medical test available. Management focuses on supportive therapies and educational interventions tailored to the individual's needs.

Signs and symptoms

Core features include difficulties with social-emotional reciprocity, such as challenges in normal back-and-forth conversation and reduced sharing of interests. Individuals may exhibit nonverbal communicative behaviors deficits, including abnormalities in eye contact, body language, and understanding of gestures. Challenges in developing, maintaining, and understanding relationships, such as difficulties adjusting behavior to suit various social contexts, are common. Restricted and repetitive behaviors manifest as stereotyped or repetitive motor movements, use of objects, or speech, such as lining up toys or echolalia. Insistence on sameness, inflexible adherence to routines, or ritualized patterns of verbal or nonverbal behavior can cause significant distress. Highly restricted, fixated interests that are abnormal in intensity or focus, such as a preoccupation with train schedules or vacuum cleaners, are often present. Hyper- or hyporeactivity to sensory input, such as adverse responses to specific sounds or textures, is also frequently reported. These symptoms are present from early childhood and limit or impair everyday functioning.

Causes

The etiology is complex and involves a combination of genetic and environmental influences. Strong evidence from twin studies and family studies indicates a high heritability component, with numerous genes implicated, though no single gene accounts for most cases. Known genetic conditions associated with an increased likelihood include Fragile X syndrome, Tuberous sclerosis, and Rett syndrome. Advanced parental age, particularly advanced paternal age, has been identified as a risk factor. Certain prenatal exposures, such as to the medications valproic acid or thalidomide, are also linked to increased risk. Complications during pregnancy or childbirth, such as extreme prematurity or very low birth weight, may contribute. Extensive research has found no credible evidence supporting a link between ASD and vaccines, a claim thoroughly debunked by major health organizations like the Centers for Disease Control and Prevention and the World Health Organization.

Diagnosis

Diagnosis is based on comprehensive behavioral evaluation and developmental history, as there are no biological markers. In the United States and many other countries, standard diagnostic criteria are outlined in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) published by the American Psychiatric Association. The diagnostic process typically involves a multidisciplinary team that may include a developmental pediatrician, a child psychiatrist, or a clinical psychologist. Standardized assessment tools, such as the Autism Diagnostic Observation Schedule (ADOS) and the Autism Diagnostic Interview-Revised (ADI-R), are commonly used. Diagnosis can sometimes be made as early as 18-24 months of age, though many individuals, particularly those without co-occurring intellectual disability or those assigned female at birth, may be diagnosed later in childhood, adolescence, or even adulthood.

Management

There is no cure, and management is supportive, aiming to maximize functional independence and quality of life. Interventions are highly individualized and often include applied behavior analysis (ABA), a widely used behavioral therapy. Speech-language pathology addresses challenges in communication, while occupational therapy can help with sensory issues and daily living skills. Educational support through Individualized Education Programs (IEPs) in schools is critical. Some individuals may benefit from social skills training. Pharmacological treatment is not for core symptoms but may be used to manage co-occurring conditions such as anxiety, depression, attention deficit hyperactivity disorder, or epilepsy. There is no scientific support for many alternative therapies, such as chelation therapy, which can be dangerous.

Prognosis

Outcomes vary tremendously and are influenced by factors like the presence of intellectual disability, language ability, and access to early intervention. Some individuals require significant lifelong support in daily living, while others live independently and pursue higher education and careers. The development of functional language by age five or six is often a positive prognostic indicator. Co-occurring conditions, such as intellectual disability or epilepsy, can significantly impact long-term functioning. Many adults report improved social understanding and coping strategies over time, though core challenges typically persist.

Epidemiology

Recent estimates from the Centers for Disease Control and Prevention indicate that approximately 1 in 36 children in the United States is identified with the condition. It is reported to occur in all racial, ethnic, and socioeconomic groups, though disparities exist in the timing of diagnosis and access to services. It is diagnosed more frequently in males than in females, with a ratio historically estimated at around 4:1. Prevalence figures have increased over recent decades, largely due to broadened diagnostic criteria, increased awareness, and improved identification.

History

The modern conceptualization stems from the independent work of two Austrian-American psychiatrists, Leo Kanner and Hans Asperger, in the 1940s. Kanner first described "early infantile autism" in 1943, while Asperger described a similar condition, later termed Asperger syndrome. For decades, it was considered a form of childhood schizophrenia, a view changed by the work of researchers like Bernard Rimland. The condition was formally included in the DSM-III in 1980. The spectrum concept was solidified with the publication of the DSM-5 in 2013, which merged previous separate diagnoses into a single category. The neurodiversity movement, championed by advocates like Temple Grandin and organizations such as Autism Network International, has significantly influenced societal understanding and acceptance. Category:Neurodevelopmental disorders Category:Psychiatric diagnosis Category:Disability